Although platelet derived TSP-1 level appears not to be a marker for NSCLC, NPAA may be more of value than platelet derived VEGF in the diagnostic and prognosis of non-small cell lung cancer. This evidence concerns the gene THBS1 and non-small cell lung carcinoma.